Vyvanse and Glucose Intolerance in Children With ADHD and Obesity.
Phase of Trial: Phase IV
Latest Information Update: 21 Apr 2014
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 16 Nov 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
- 12 Jun 2011 Planned end date changed from 1 May 2011 to 1 May 2012 as reported by ClinicalTrials.gov.